BIOMAT Database Logo BIOMAT Database Logo

High-sensitivity troponin in marathon runners. 2013

Daniel M Fatovich, and Michael R Phillips, and Kelley M Hubble, and Samuel D Vasikaran

UI MeSH Term Description Entries
D008297 Male Males
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays
D012420 Running An activity in which the body is propelled by moving the legs rapidly. Running is performed at a moderate to rapid pace and should be differentiated from JOGGING, which is performed at a much slower pace. Runnings
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D014336 Troponin One of the minor protein components of skeletal and cardiac muscles. It functions as the calcium-binding component in a complex with BETA-TROPOMYOSIN; ACTIN; and MYOSIN and confers calcium sensitivity to the cross-linked actin and myosin filaments. Troponin itself is a complex of three regulatory proteins (TROPONIN C; TROPONIN I; and TROPONIN T). Troponin Complex,Troponins
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

Daniel M Fatovich, and Michael R Phillips, and Kelley M Hubble, and Samuel D Vasikaran
High-sensitivity troponin T in marathon runners, marathon runners with heart disease and collapsed marathon runners.
May 2019, Scandinavian journal of medicine & science in sports,
Daniel M Fatovich, and Michael R Phillips, and Kelley M Hubble, and Samuel D Vasikaran
High-sensitivity cardiac troponin T release after a single bout of high-intensity interval exercise in experienced marathon runners.
December 2017, Journal of exercise science and fitness,
Daniel M Fatovich, and Michael R Phillips, and Kelley M Hubble, and Samuel D Vasikaran
Cardiac troponin increases among marathon runners in the Perth Marathon: the Troponin in Marathons (TRIM) study.
January 2009, The Medical journal of Australia,
Daniel M Fatovich, and Michael R Phillips, and Kelley M Hubble, and Samuel D Vasikaran
Cardiac troponin increases among runners in the Boston Marathon.
February 2007, Annals of emergency medicine,
Daniel M Fatovich, and Michael R Phillips, and Kelley M Hubble, and Samuel D Vasikaran
Cardiac troponin T release and inflammation demonstrated in marathon runners.
January 2010, Clinical laboratory,
Daniel M Fatovich, and Michael R Phillips, and Kelley M Hubble, and Samuel D Vasikaran
Cardiac Troponin T: Only Small Molecules in Recreational Runners After Marathon Completion.
March 2019, The journal of applied laboratory medicine,
Daniel M Fatovich, and Michael R Phillips, and Kelley M Hubble, and Samuel D Vasikaran
Effect of Health and Training on Ultrasensitive Cardiac Troponin in Marathon Runners.
March 2019, The journal of applied laboratory medicine,
Daniel M Fatovich, and Michael R Phillips, and Kelley M Hubble, and Samuel D Vasikaran
Elevated high-density lipoprotein levels in marathon runners.
February 1980, JAMA,
Daniel M Fatovich, and Michael R Phillips, and Kelley M Hubble, and Samuel D Vasikaran
The increased sensitivity of platelets to prostacyclin in marathon runners.
July 1984, Thrombosis and haemostasis,
Daniel M Fatovich, and Michael R Phillips, and Kelley M Hubble, and Samuel D Vasikaran
Comparison of conventional and highly-sensitive troponin I measurement in ultra-marathon runners.
May 2012, Journal of thrombosis and thrombolysis,
Copied contents to your clipboard!